Literature DB >> 18376983

Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).

Xiao Dong1, Wei Chen, Normand Mousseau, Philippe Derreumaux.   

Abstract

The cytotoxicity of Alzheimer's disease has been linked to the self-assembly of the 4042 amino acid of the amyloid-beta (Abeta) peptide into oligomers. To understand the assembly process, it is important to characterize the very first steps of aggregation at an atomic level of detail. Here, we focus on the N-terminal fragment 1-28, known to form fibrils in vitro. Circular dichroism and NMR experiments indicate that the monomer of Abeta(1-28) is alpha-helical in a membranelike environment and random coil in aqueous solution. Using the activation-relaxation technique coupled with the OPEP coarse grained force field, we determine the structures of the monomer and of the dimer of Abeta(1-28). In agreement with experiments, we find that the monomer is predominantly random coil in character, but displays a non-negligible beta-strand probability in the N-terminal region. Dimerization impacts the structure of each chain and leads to an ensemble of intertwined conformations with little beta-strand content in the region Leu17-Ala21. All these structural characteristics are inconsistent with the amyloid fibril structure and indicate that the dimer has to undergo significant rearrangement en route to fibril formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376983     DOI: 10.1063/1.2890033

Source DB:  PubMed          Journal:  J Chem Phys        ISSN: 0021-9606            Impact factor:   3.488


  7 in total

1.  A study of the α-helical intermediate preceding the aggregation of the amino-terminal fragment of the β amyloid peptide (Aβ(1-28)).

Authors:  Ana V Rojas; Adam Liwo; Harold A Scheraga
Journal:  J Phys Chem B       Date:  2011-10-18       Impact factor: 2.991

2.  A molecular dynamics study of the early stages of amyloid-beta(1-42) oligomerization: the role of lipid membranes.

Authors:  Charles H Davis; Max L Berkowitz
Journal:  Proteins       Date:  2010-08-15

Review 3.  Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.

Authors:  Jing Liu; Bin Yang; Jun Ke; Wenjia Li; Wen-Chen Suen
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 4.  Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

5.  Computational study of the binding of CuII to Alzheimer's amyloid-beta peptide: do Abeta42 and Abeta40 bind copper in identical fashion?

Authors:  Yogita Mantri; Marco Fioroni; Mu-Hyun Baik
Journal:  J Biol Inorg Chem       Date:  2008-07-08       Impact factor: 3.358

6.  Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formation.

Authors:  Igor F Tsigelny; Yuriy Sharikov; Valentina L Kouznetsova; Jerry P Greenberg; Wolfgang Wrasidlo; Tania Gonzalez; Paula Desplats; Sarah E Michael; Margarita Trejo-Morales; Cassia R Overk; Eliezer Masliah
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Revisiting rodent models: Octodon degus as Alzheimer's disease model?

Authors:  Johannes Steffen; Markus Krohn; Kristin Paarmann; Christina Schwitlick; Thomas Brüning; Rita Marreiros; Andreas Müller-Schiffmann; Carsten Korth; Katharina Braun; Jens Pahnke
Journal:  Acta Neuropathol Commun       Date:  2016-08-26       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.